Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Ellen K ChangDayana ChansonJennifer Berano TehAleksi IukuridzeKelly PengStephen J FormanRyotaro NakamuraF Lennie WongLiYing CaiSaro H ArmenianPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
The burden of AF after allogeneic HCT population is substantial, and the development of AF is associated with poor survival. We identified important associations between patient demographics, pre-HCT cardiac parameters, HCT-related exposures, and risk of AF, setting the stage for targeted prevention strategies during and after HCT.
Keyphrases
- atrial fibrillation
- cell cycle arrest
- stem cell transplantation
- patients undergoing
- bone marrow
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- cell death
- percutaneous coronary intervention
- case report
- left ventricular
- air pollution
- hematopoietic stem cell
- pi k akt
- high dose
- risk factors
- cancer therapy
- coronary artery disease
- acute coronary syndrome
- drug delivery
- mitral valve
- venous thromboembolism
- signaling pathway